Author:
Castellsagué Xavier,Ault Kevin A.,Bosch F. Xavier,Brown Darron,Cuzick Jack,Ferris Daron G.,Joura Elmar A.,Garland Suzanne M.,Giuliano Anna R,Hernandez-Avila Mauricio,Huh Warner,Iversen Ole-Erik,Kjaer Susanne K.,Luna Joaquin,Monsonego Joseph,Muñoz Nubia,Myers Evan,Paavonen Jorma,Pitisuttihum Punnee,Steben Marc,Wheeler Cosette M.,Perez Gonzalo,Saah Alfred,Luxembourg Alain,Sings Heather L,Velicer Christine
Subject
Infectious Diseases,Virology
Reference29 articles.
1. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women;Joura;N. Engl. J. Med.,2015
2. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 100, A Review of Human Carcinogens, Part B: Biological Agents;International Agency for Research on Cancer,2012
3. Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease;Serrano;Infect. Agent Cancer,2012
4. Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease;Joura;Cancer Epidemiol. Biomark. Prev.,2014
5. Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications;Goldie;Reprod. Health Matters,2008
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献